Bronte Capital Management Pty »

Regeneron Pharmaceuticals shares owned by Bronte Capital Management Pty

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Bronte Capital Management Pty from 13F filings

Historical chart of Bronte Capital Management Pty investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Bronte Capital Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Bronte Capital Management Pty

Quarter filed Position value Share count Share price at filing
2023-12-31 $128M 145k 878.29
2023-09-30 $116M 141k 822.96
2023-06-30 $99M 138k 718.54
2023-03-31 $112M 136k 821.67
2022-12-31 $103M 143k 721.49
2022-09-30 $101M 147k 688.87
2022-06-30 $88M 149k 591.13
2022-03-31 $97M 139k 698.42
2021-12-31 $82M 131k 631.52
2021-09-30 $75M 124k 605.18
2021-06-30 $66k 118k 0.56
2021-03-31 $28k 59k 0.47
2020-12-31 $9.2M 19k 483.13